Form 8-K
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 9, 2009

 

 

QuadraMed Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32283   52-1992861

(State or Other Jurisdiction

of Incorporation)

   (Commission File Number)  

(I.R.S. Employer

Identification No.)

12110 Sunset Hills Road, Suite 600, Reston, VA 20190

(Address of principal executive office and zip code)

(703) 709-2300

(Registrant’s telephone number, including area code)

(Not Applicable)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Table of Contents

TABLE OF CONTENTS

 

ITEM 2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITION    3
ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS    3
SIGNATURES    4
EXHIBIT INDEX    5
EXHIBIT 99.1    QUADRAMED CORPORATION PRESS RELEASE, DATED FEBRUARY 9, 2009.   
     

Table of Contents
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On February 9, 2009, QuadraMed Corporation (the “Company”) issued a press release announcing preliminary revenue and other financial information with respect to fiscal year 2008.

A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference in response to this Item 2.02.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

 

Exhibit 99.1   QuadraMed Corporation Press Release, dated February 9, 2009.

 

3

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 10, 2009

 

QuadraMed Corporation

/s/ David L. Piazza

David L. Piazza,
Executive Vice President and Chief Financial Officer

 

4

Table of Contents

EXHIBIT INDEX

 

Exhibit No.

  

Description

99.1

   QuadraMed Corporation Press Release, dated February 9, 2009.

 

5